Trinity-Chiesi launches CFC-free beclometasone MDI

Trinity-Chiesi has launched Clenil Modulite, a CFC-free metered dose inhaler delivering 50, 100, 200 or 250 microgram beclometasone dipropionate per actuation for the prevention of asthma in adults and children.

The bioavailability of beclometasone delivered by Clenil Modulite is the same as that delivered by CFC-propelled beclometasone MDIs. Consequently, when transferring patients from a CFC-propelled MDI to Clenil Modulite, there is no need to adjust the dose.

As the bioavailability of different makes of CFC-free beclometasone MDIs varies, doctors are advised to prescribe such products by brand name to ensure that patients receive the same product and the correct dose each time.

Further information: Trinity-Chiesi Pharmaceuticals Ltd, Cheadle Royal Business Park, Highfield, Cheshire SK8 3GY. Tel: (0161) 488 5555.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more